Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer
MindCRC
Mindfulness and CRC Risk Factor Reduction: Targeting Chronic Stress For Colorectal Cancer Risk Factor Reduction A Pilot Feasibility Study Among Vulnerable At-Risk Black Females
1 other identifier
interventional
24
1 country
1
Brief Summary
Many neighborhoods in Chicago experience daily exposure to stressors including economic inopportunity and violent crime in public spaces. There is mounting evidence that chronic psychosocial stress can facilitate carcinogenesis by modulating the gut microbiome and immune system. The proposed research aims to study the practice of mindfulness to mitigate CPS and reduce colorectal cancer risk factors among Black American women at elevated risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2024
CompletedFirst Posted
Study publicly available on registry
March 21, 2024
CompletedStudy Start
First participant enrolled
July 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedNovember 21, 2025
November 1, 2025
1 year
March 1, 2024
November 19, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Feasibility measures
easible if ≥ 30% of those approached enroll at a minimum rate of 1-3 women/week for each wave and ≥ 80% of women enrolled are retained with complete data collection at both assessment time-point
Monitored across the duration of study and 8-week intervention
Acceptability
The intervention will be deemed acceptable if women attend ≥ 80% of the Mindfulness group sessions, engage with ≥ 80% of the asynchronous Mindfulness content and score ≥ 16 on the acceptability survey.
Week 4 and post-intervention at week 9
Other Outcomes (14)
Body mass index
Baseline and post-intervention at week 9
Stress measure
Baseline and post-intervention at week 9
Fasting glucose
Baseline and post-intervention at week 9
- +11 more other outcomes
Study Arms (1)
Mindfulness
EXPERIMENTAL8-week group and individual mindfulness training and practice
Interventions
Participants attend seven 60-90 min group mindfulness sessions each week and a 1/2 day retreat, with three sessions in-person and six sessions remote, led by a mindfulness interventionist. Additionally, participants will be encouraged to engage for at least 30 minutes per week in asynchronous mindfulness activities through a web-based program to increase exposure to mindfulness practices beyond group sessions.
Eligibility Criteria
You may qualify if:
- Female based on sex assigned at birth
- Self-identify as Black
- Age 45-65 years old
- Completed a colonoscopy in the past 24 months,
- Classify as elevated risk of CRC defined as: any colorectal adenoma detected in past 24 months
- Own and use a smartphone, computer, or tablet with access to the Internet
- Score ≥ 14 on the PSS at screening
- Reside in a Chicago community with high violent crime
You may not qualify if:
- History of CRC
- Antibiotics (oral/IV) in the past 2 months
- Inflammatory bowel disease or genetic predisposition to CRC
- Cancer diagnosis or cancer treatment in the past 12 months
- Consume \> 50 grams of ethanol daily
- Use combustible tobacco
- Bariatric surgery or bowel resection
- Immunodeficiency/autoimmune disease
- Uncontrolled diabetes (HbA1c \> 9% based on EHR)
- Fiber or pre-/probiotic supplements \> 3 days per week
- Serrated adenoma at the recent colonoscopy given the molecular features are distinct
- Significant health conditions or take medications that impact participation or expected outcomes (e.g., β-blocker, Cushing's syndrome, and corticosteroids - inhaled, topical, oral in the past month given effects on hair cortisol measurement)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois Chicago
Chicago, Illinois, 60612, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 1, 2024
First Posted
March 21, 2024
Study Start
July 15, 2024
Primary Completion
July 15, 2025
Study Completion
August 31, 2025
Last Updated
November 21, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share